Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Cash from Operations (2020 - 2025)

Historic Cash from Operations for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to -$2.7 million.

  • IceCure Medical's Cash from Operations rose 1420.87% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.8 million, marking a year-over-year decrease of 2884.18%. This contributed to the annual value of -$12.6 million for FY2024, which is 10.36% down from last year.
  • Latest data reveals that IceCure Medical reported Cash from Operations of -$2.7 million as of Q3 2025, which was up 1420.87% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Cash from Operations registered a high of -$1.7 million during Q2 2021, and its lowest value of -$5.9 million during Q4 2021.
  • In the last 5 years, IceCure Medical's Cash from Operations had a median value of -$3.2 million in 2021 and averaged -$3.2 million.
  • In the last 5 years, IceCure Medical's Cash from Operations tumbled by 32990.52% in 2021 and then skyrocketed by 4418.6% in 2023.
  • Quarter analysis of 5 years shows IceCure Medical's Cash from Operations stood at -$5.9 million in 2021, then increased by 29.96% to -$4.1 million in 2022, then skyrocketed by 44.19% to -$2.3 million in 2023, then tumbled by 82.07% to -$4.2 million in 2024, then soared by 35.52% to -$2.7 million in 2025.
  • Its Cash from Operations stands at -$2.7 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$4.0 million for Q1 2025.